ID

37702

Descripción

Study ID: 104864/517 Clinical Study ID: 104864/517 Study Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00158886 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Topotecan + Radiation therapy Trade Name: N/A Study Indication: Rectal Cancer, Carcinoma, Renal Cell

Palabras clave

Versiones (1)
  1. 19/8/19 19/8/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

19 de agosto de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Oral Topotecan as Radiosensitizing Agent in Patients with Rectal Cancer; NCT00158886

Inglés

Post RT/Prior to Surgery

1 formularios  
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Center number
Descripción

Study Coordinating Center, Identification number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2825181
UMLS CUI [1,2]
C1300638
Patient Number
Descripción

Patient number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1830427
Patient Initials
Descripción

Person Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Visit Date
Descripción

Date of visit

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
Serious Adverse Experience
Descripción

Serious Adverse Experience

Alias
UMLS CUI-1
C1519255
Has the patient had any serious adverse experiences during this course?
Descripción

Serious Adverse Event

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519255
12-Lead Electrocardiogram
Descripción

12-Lead Electrocardiogram

Alias
UMLS CUI-1
C0430456
Required only if clinically indicated. Mark the box if not required.
Descripción

12 lead ECG, Requirement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C1514873
Date Performed
Descripción

12 lead ECG, Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C0011008
Result
Descripción

12 lead ECG, Result

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0430456
UMLS CUI [1,2]
C0011008
Study Medication Compliance
Descripción

Study Medication Compliance

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C1321605
Number of Capsules Dispensed - 1.0 mg
Descripción

Experimental drug, Topotecan, Capsules, Amount Dispensed

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Number of Capsules Dispensed - 0.25 mg
Descripción

Experimental drug, Topotecan, Capsules, Amount Dispensed

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Number of Capsules Taken - 1.0 mg
Descripción

Experimental drug, Topotecan, Capsules, Taken

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C1883727
Number of Capsules Taken - 0.25 mg
Descripción

Experimental drug, Topotecan, Capsules, Taken

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C1883727
Number of Capsules Returned - 1.0 mg
Descripción

Experimental drug, Topotecan, Capsules, Amount Returned

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Number of Capsules Returned - 0.25 mg
Descripción

Experimental drug, Topotecan, Capsules, Amount Returned

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Volver a la parte superior de la página

Similar models

Post RT/Prior to Surgery

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Study Coordinating Center, Identification number
Item
Center number
integer
C2825181 (UMLS CUI [1,1])
C1300638 (UMLS CUI [1,2])
Patient number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Person Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Date of visit
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
Serious Adverse Experience
C1519255 (UMLS CUI-1)
Serious Adverse Event
Item
Has the patient had any serious adverse experiences during this course?
boolean
C1519255 (UMLS CUI [1])
Item Group
12-Lead Electrocardiogram
C0430456 (UMLS CUI-1)
12 lead ECG, Requirement
Item
Required only if clinically indicated. Mark the box if not required.
boolean
C0430456 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
12 lead ECG, Date in time
Item
Date Performed
date
C0430456 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Result
text
C0430456 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
12 lead ECG, Result
Code List
Result
CL Item
No significant worsening since screening (1)
CL Item
Worsening since screening (2)
Item Group
Study Medication Compliance
C0304229 (UMLS CUI-1)
C1321605 (UMLS CUI-2)
Experimental drug, Topotecan, Capsules, Amount Dispensed
Item
Number of Capsules Dispensed - 1.0 mg
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsules, Amount Dispensed
Item
Number of Capsules Dispensed - 0.25 mg
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsules, Taken
Item
Number of Capsules Taken - 1.0 mg
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C1883727 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsules, Taken
Item
Number of Capsules Taken - 0.25 mg
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C1883727 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsules, Amount Returned
Item
Number of Capsules Returned - 1.0 mg
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsules, Amount Returned
Item
Number of Capsules Returned - 0.25 mg
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial